An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.
Bill status
in committee
3 of 5 stages cleared
Introduction
Jul 2021
Committee Review
Jun 2022
House Passage
Jun 2022
Senate Passage
Governor
Introduced Jul 30, 2021
Last action Jun 14, 2022
Floor votes · House Jun 14, 2022
How they voted
106–84
Passed · 2 other
Total votes 192
Jun 14, 2022
D
Democratic84
98% Nay
R
Republican108
98% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
10
Key actions
2
Committee
2
Amendments
1
Jun 14, 2022
House · Passed
House Vote: pass (106-84-2)
house
Jun 14, 2022
Committee
Re-committed to APPROPRIATIONS
lower
Feb 7, 2022
Lower · Passed
PN 2713 Reported as amended
lower
Jul 30, 2021
Committee
PN 1972 Referred to HEALTH
lower
1 primary · 17 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Dawn Keefer
RRepublican
Co
Aaron Bernstine
RRepublican
Co
Craig Staats
RRepublican
Co
Dave Zimmerman
RRepublican
Co
David Maloney
RRepublican
Co
David Rowe
RRepublican
Co
Francis X. Ryan
RRepublican
Co
Jim Cox
RRepublican
Co
Joe Hamm
RRepublican
Co
Johnathan D. Hershey
RRepublican
Co
Kathy Rapp
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 1741
Scope: PA
Hi! I can help you understand HB 1741. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline